Published in Neuropsychopharmacology on January 13, 2010
Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl Psychiatry (2012) 1.22
Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia. PLoS One (2012) 1.07
Disrupted circadian rhythms in a mouse model of schizophrenia. Curr Biol (2012) 0.96
Postmortem brain: an underutilized substrate for studying severe mental illness. Neuropsychopharmacology (2013) 0.91
Regulation of intracellular membrane trafficking and cell dynamics by syntaxin-6. Biosci Rep (2012) 0.88
Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia. Biol Psychiatry (2014) 0.87
Synaptic protein deficits are associated with dementia irrespective of extreme old age. Neurobiol Aging (2011) 0.83
New insights into behaviour using mouse ENU mutagenesis. Hum Mol Genet (2012) 0.80
Mice deficient in transmembrane prostatic acid phosphatase display increased GABAergic transmission and neurological alterations. PLoS One (2014) 0.79
Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample. Mol Neurodegener (2015) 0.79
Dysregulations of Synaptic Vesicle Trafficking in Schizophrenia. Curr Psychiatry Rep (2016) 0.78
Targeting synaptic pathology with a novel affinity mass spectrometry approach. Mol Cell Proteomics (2014) 0.78
SNARE complex in developmental psychiatry: neurotransmitter exocytosis and beyond. J Neural Transm (Vienna) (2016) 0.78
ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype. J Psychiatry Neurosci (2011) 0.78
SNAP-25a/b Isoform Levels in Human Brain Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex. Mol Neuropsychiatry (2015) 0.75
Altered neuronal markers following treatment with mood stabilizer and antipsychotic drugs indicate an increased likelihood of neurotransmitter release. Clin Psychopharmacol Neurosci (2012) 0.75
Quantitative mass spectrometry reveals changes in SNAP-25 isoforms in schizophrenia. Schizophr Res (2016) 0.75
SNAP receptors implicated in vesicle targeting and fusion. Nature (1993) 18.57
Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci (2004) 5.55
The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat (2003) 5.16
The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain (1999) 5.13
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci (2008) 5.12
Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry (2009) 3.67
Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry (2000) 2.68
The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett (1995) 2.35
Differential control of the releasable vesicle pools by SNAP-25 splice variants and SNAP-23. Cell (2003) 2.25
Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J Clin Invest (2009) 1.87
Functional disconnectivity in subjects at high genetic risk of schizophrenia. Brain (2005) 1.41
Gene expression profiling in the post-mortem human brain--no cause for dismay. J Chem Neuroanat (2001) 1.36
Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology (2002) 1.33
Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol Psychiatry (2007) 1.32
Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci (2005) 1.25
Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol Psychiatry (2003) 1.23
Distinct patterns of expression of two VAMP genes within the rat brain. J Neurosci (1990) 1.22
A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse. Proc Natl Acad Sci U S A (2007) 1.22
Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport (2001) 1.20
Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb Cortex (2002) 1.18
Volume, neuron density and total neuron number in five subcortical regions in schizophrenia. Brain (2007) 1.14
Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord (2005) 1.12
Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry (2005) 1.11
Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J Neurosci (1996) 1.10
SNARE complex regulation by phosphorylation. Cell Biochem Biophys (2006) 1.10
Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents. Obesity (Silver Spring) (2006) 1.09
Electrophysiological interactions between striatal glutamatergic and dopaminergic systems. Ann N Y Acad Sci (2003) 1.08
SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex (1998) 1.08
Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder. Bipolar Disord (2006) 1.07
Reduced density of cholinergic interneurons in the ventral striatum in schizophrenia: an in situ hybridization study. Biol Psychiatry (2005) 1.07
Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol Psychiatry (1998) 1.05
The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res (1985) 1.05
SNAP-25 in neuropsychiatric disorders. Ann N Y Acad Sci (2009) 1.05
Measurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay. J Neurosci Methods (2004) 1.04
D-amino acid oxidase activity and expression are increased in schizophrenia. Mol Psychiatry (2008) 1.04
Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience (1997) 1.04
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia. Neurosci Lett (2005) 1.02
Morphometric study of synaptic patterns in the rat caudate nucleus and hippocampus under haloperidol treatment. Synapse (1991) 1.01
Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Mol Psychiatry (1999) 1.01
The SNAP-25 gene is associated with cognitive ability: evidence from a family-based study in two independent Dutch cohorts. Mol Psychiatry (2006) 1.01
Spontaneous locomotor hyperactivity in a mouse mutant with a deletion including the Snap gene on chromosome 2. J Neurosci (1992) 0.99
Evidence for disruption of sphingolipid metabolism in schizophrenia. J Neurosci Res (2009) 0.99
Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk. Hum Mol Genet (2009) 0.99
Persistence of haloperidol in human brain tissue. Am J Psychiatry (1999) 0.98
Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia. Schizophr Res (2008) 0.97
Heterogeneous expression of SNAP-25 in rat and human brain. J Comp Neurol (2008) 0.97
Coloboma hyperactive mutant mice exhibit regional and transmitter-specific deficits in neurotransmission. J Neurochem (1997) 0.96
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics. Eur Arch Psychiatry Clin Neurosci (2008) 0.96
Developmental and plasticity-related differential expression of two SNAP-25 isoforms in the rat brain. J Comp Neurol (1996) 0.95
Asymmetric accumulation of hippocampal 7S SNARE complexes occurs regardless of kindling paradigm. Epilepsy Res (2006) 0.95
Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat. Biol Psychiatry (2005) 0.94
Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol Psychiatry (2002) 0.94
Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. Arch Gen Psychiatry (1997) 0.93
D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD. Neurobiol Dis (2006) 0.91
Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics. Neurosci Lett (2002) 0.89
Presynaptic proteins and schizophrenia. Int Rev Neurobiol (2004) 0.89
Differential distribution of syntaxin isoforms 1A and 1B in the rat central nervous system. Eur J Neurosci (1996) 0.89
SNAP-25 genotype influences NAA/Cho in left hippocampus. J Neural Transm (Vienna) (2008) 0.88
Inhibition of SNAP-25 phosphorylation at Ser187 is involved in chronic morphine-induced down-regulation of SNARE complex formation. J Biol Chem (2004) 0.88
Synaptic differences in the postmortem striatum of subjects with schizophrenia: a stereological ultrastructural analysis. Synapse (2005) 0.88
Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia. J Neural Transm Suppl (2007) 0.88
Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum. Synapse (1995) 0.88
Abnormal presynaptic catecholamine regulation in a hyperactive SNAP-25-deficient mouse mutant. Pharmacol Biochem Behav (2001) 0.87
SNAP-25 gene polymorphisms and weight gain in schizophrenic patients. J Psychiatr Res (2008) 0.87
Association between schizophrenia and the syntaxin 1A gene. Biol Psychiatry (2004) 0.86
Elevated cerebrospinal fluid SNAP-25 in schizophrenia. Biol Psychiatry (2003) 0.86
Evidence that putative ADHD low risk alleles at SNAP25 may increase the risk of schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2009) 0.85
Upregulation of NRG-1 and VAMP-1 in human brain aggregates exposed to clozapine. Schizophr Res (2009) 0.84
Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia. Synapse (2008) 0.83
Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuropharmacol (1992) 0.82
Selective effects of typical antipsychotic drugs on SNAP-25 and synaptophysin in the hippocampal trisynaptic pathway. Int J Neuropsychopharmacol (2005) 0.82
Antidepressants and gene expression profiling: how to SNARE novel drug targets. Pharmacogenomics J (2002) 0.82
Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses. J Neurochem (1996) 0.82
Coloboma hyperactive mutant exhibits delayed neurobehavioral developmental milestones. Brain Res Dev Brain Res (1995) 0.81
Studies on cholecystokinin-containing neuronal pathways in rat cerebral cortex and striatum. Ann N Y Acad Sci (1985) 0.80
Increase in syntaxin 1B mRNA in hippocampal and cortical circuits during spatial learning reflects a mechanism of trans-synaptic plasticity involved in establishing a memory trace. Learn Mem (1999) 0.79
Functional imaging research in schizophrenia. Int Rev Neurobiol (2005) 0.79
Synaptic differences in the patch matrix compartments of subjects with schizophrenia: a postmortem ultrastructural study of the striatum. Neurobiol Dis (2005) 0.79
A search for synthetic peptides that inhibit soluble N-ethylmaleimide sensitive-factor attachment receptor-mediated membrane fusion. FEBS J (2008) 0.79
Morphological abnormalities in nitric-oxide-synthase-positive striatal interneurons of schizophrenic patients. Neuropsychobiology (2005) 0.79
Small peptides patterned after the N-terminus domain of SNAP25 inhibit SNARE complex assembly and regulated exocytosis. J Neurochem (2004) 0.78
CSF SNAP-25 in schizophrenia and bipolar illness. A pilot study. Neuropsychopharmacology (1999) 0.77
Modulation of the SNARE core complex by dopamine. Can J Physiol Pharmacol (2000) 0.77
Inhibition of SNARE-driven neuroexocytosis by plant extracts. Biotechnol Lett (2008) 0.76
Identification of SNARE complex modulators that inhibit exocytosis from an alpha-helix-constrained combinatorial library. Biochem J (2003) 0.76
A radioassay for synaptic core complex assembly: screening of herbal extracts for effectors. Anal Biochem (2006) 0.76
Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage (2009) 11.90
The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry (2011) 9.18
Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry (2007) 6.80
Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell (2008) 5.93
Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med (2002) 4.77
Clozapine alone versus clozapine and risperidone with refractory schizophrenia. N Engl J Med (2006) 4.16
Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry (2006) 3.44
Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry (2010) 3.42
Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry (2012) 3.29
A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell (2009) 3.28
The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry (2005) 3.24
Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry (2012) 3.24
Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry (2004) 3.19
Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron (2002) 3.06
Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. Am J Psychiatry (2011) 3.04
Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. Br J Psychiatry (2005) 2.84
Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol (2013) 2.78
Familial pathways to early-onset suicide attempt: risk for suicidal behavior in offspring of mood-disordered suicide attempters. Arch Gen Psychiatry (2002) 2.76
Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry (2009) 2.76
Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology (2009) 2.63
Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. Am J Psychiatry (2007) 2.52
DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. Hum Mol Genet (2006) 2.50
Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science (2006) 2.49
Varenicline, smoking cessation, and neuropsychiatric adverse events. Am J Psychiatry (2013) 2.46
The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci (2006) 2.46
microRNA-34c is a novel target to treat dementias. EMBO J (2011) 2.44
Familial pathways to early-onset suicidal behavior: familial and individual antecedents of suicidal behavior. Am J Psychiatry (2007) 2.43
Family genetic studies, suicide, and suicidal behavior. Am J Med Genet C Semin Med Genet (2005) 2.43
Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med (2010) 2.32
Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry (2006) 2.31
Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J Neurosci (2011) 2.21
Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography. Biol Psychiatry (2005) 2.16
Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J Neurosci (2007) 2.12
Instability of symptoms in recurrent major depression: a prospective study. Am J Psychiatry (2004) 2.12
Safety and efficiency of emergency department assessment of chest discomfort. CMAJ (2004) 2.09
Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. J Clin Invest (2006) 2.08
Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry (2005) 2.06
Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med (2014) 2.05
Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned? Drug Saf (2011) 2.05
Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry (2005) 2.03
Fear is only as deep as the mind allows: a coordinate-based meta-analysis of neuroimaging studies on the regulation of negative affect. Neuroimage (2011) 2.02
11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med (2009) 1.99
Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry (2006) 1.96
Adequacy of antidepressant treatment after discharge and the occurrence of suicidal acts in major depression: a prospective study. Am J Psychiatry (2002) 1.95
Issues for DSM-V: suicidal behavior as a separate diagnosis on a separate axis. Am J Psychiatry (2008) 1.92
A regulatory toolbox of MiniPromoters to drive selective expression in the brain. Proc Natl Acad Sci U S A (2010) 1.85
Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology (2004) 1.82
Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry (2011) 1.81
Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J Neurosci (2008) 1.80
Posttraumatic stress disorder comorbid with major depression: factors mediating the association with suicidal behavior. Am J Psychiatry (2005) 1.78
Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry (2003) 1.78
Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry (2005) 1.77
Testosterone levels in suicide attempters with bipolar disorder. J Psychiatr Res (2012) 1.72
Antidepressants and suicide risk in the United States, 1985-1999. J Clin Psychiatry (2004) 1.72
Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res (2002) 1.71
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry (2012) 1.69
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. World J Biol Psychiatry (2009) 1.64
Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend (2012) 1.62
Absence of histological lesions in primate models of ECT and magnetic seizure therapy. Am J Psychiatry (2004) 1.60
Are BPI and BPII suicide attempters distinct neuropsychologically? J Affect Disord (2006) 1.60
Structure, process, and outcome of all intensive care units within the province of British Columbia, Canada. J Intensive Care Med (2010) 1.55
Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. Am J Psychiatry (2003) 1.55
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry (2012) 1.55
Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: a cross-sectional study. Biol Psychiatry (2012) 1.53
The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am J Psychiatry (2006) 1.52
Serotonin brain circuits involved in major depression and suicide. Prog Brain Res (2002) 1.52
The relationship between organizational culture and family satisfaction in critical care. Crit Care Med (2012) 1.52
Religious affiliation and suicide attempt. Am J Psychiatry (2004) 1.51
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium. Acta Neuropathol (2008) 1.51
An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology (2004) 1.49
Functional neuroimaging of working memory in schizophrenia: task performance as a moderating variable. Neuropsychology (2006) 1.49
Reliability of the knee examination in osteoarthritis: effect of standardization. Arthritis Rheum (2004) 1.46
Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls. World J Biol Psychiatry (2010) 1.45
Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates. PLoS One (2011) 1.45
Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology (2006) 1.45
Sex differences in clinical predictors of suicidal acts after major depression: a prospective study. Am J Psychiatry (2007) 1.45
The role of the human ventral striatum and the medial orbitofrontal cortex in the representation of reward magnitude - an activation likelihood estimation meta-analysis of neuroimaging studies of passive reward expectancy and outcome processing. Neuropsychologia (2012) 1.44
Post-approval drug safety surveillance. Annu Rev Public Health (2010) 1.43
The impact of prolonged continuous wakefulness on resident clinical performance in the intensive care unit: a patient simulator study. Crit Care Med (2010) 1.43
A suicide prevention program in a region with a very high suicide rate. Arch Gen Psychiatry (2007) 1.42
Application of Sepsis Definitions to Pediatric Patients Admitted With Suspected Infections in Uganda. Pediatr Crit Care Med (2016) 1.41
Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res (2007) 1.40
Decreased plasma cholesterol levels during aging in transgenic mouse models of Alzheimer's disease. Exp Gerontol (2005) 1.39
[The confused patient]. MMW Fortschr Med (2014) 1.38
Relations between brain pathology and temporal lobe epilepsy. J Neurosci (2002) 1.37
Correlates of trait impulsiveness in performance measures and neuropsychological tests. Psychiatry Res (2005) 1.36
Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction. BMC Bioinformatics (2003) 1.36
Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase. J Neurochem (2003) 1.36
Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum (2009) 1.35
Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology (2006) 1.35
A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophr Bull (2003) 1.34